A detailed history of Norinchukin Bank, The transactions in Becton Dickinson & CO stock. As of the latest transaction made, Norinchukin Bank, The holds 11,023 shares of BDX stock, worth $2.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,023
Previous 9,868 11.7%
Holding current value
$2.5 Million
Previous $2.31 Million 15.22%
% of portfolio
0.06%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $255,797 - $279,983
1,155 Added 11.7%
11,023 $2.66 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $39,837 - $43,572
177 Added 1.83%
9,868 $2.31 Million
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $38,752 - $41,123
-166 Reduced 1.68%
9,691 $2.4 Million
Q4 2023

Feb 13, 2024

SELL
$232.24 - $267.23 $108,456 - $124,796
-467 Reduced 4.52%
9,857 $2.4 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $2.63 Million - $2.93 Million
10,324 New
10,324 $2.67 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $396,680 - $441,492
-1,664 Reduced 9.22%
16,379 $4.32 Million
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $113,247 - $127,859
493 Added 2.81%
18,043 $4.47 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $884,074 - $1.04 Million
-4,050 Reduced 18.75%
17,550 $4.46 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $120,634 - $624,639
2,364 Added 12.29%
21,600 $4.81 Million
Q2 2022

Aug 10, 2022

SELL
$234.74 - $275.42 $1.68 Million - $1.97 Million
-7,150 Reduced 27.1%
19,236 $4.74 Million
Q1 2022

May 12, 2022

BUY
$243.64 - $270.48 $427,344 - $474,421
1,754 Added 7.12%
26,386 $7.02 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $7.21 Million - $7.86 Million
-31,323 Reduced 55.98%
24,632 $6.19 Million
Q3 2021

Nov 09, 2021

SELL
$232.72 - $256.47 $27.6 Million - $30.4 Million
-118,437 Reduced 67.91%
55,955 $13.8 Million
Q2 2021

Aug 11, 2021

BUY
$232.65 - $254.58 $1.23 Million - $1.34 Million
5,274 Added 3.12%
174,392 $42.4 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $24.5 Million - $27.1 Million
-105,438 Reduced 38.4%
169,118 $41.1 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $5.05 Million - $5.6 Million
22,773 Added 9.04%
274,556 $68.7 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $8.99 Million - $11.5 Million
41,662 Added 19.83%
251,783 $58.6 Million
Q2 2020

Aug 12, 2020

BUY
$219.9 - $263.41 $148,212 - $177,538
674 Added 0.32%
210,121 $50.3 Million
Q1 2020

May 13, 2020

SELL
$195.69 - $279.01 $2.13 Million - $3.03 Million
-10,868 Reduced 4.93%
209,447 $48.1 Million
Q4 2019

Feb 12, 2020

BUY
$236.45 - $266.82 $19.9 Million - $22.4 Million
84,051 Added 61.68%
220,315 $59.9 Million
Q3 2019

Nov 12, 2019

BUY
$230.58 - $256.08 $11.7 Million - $13 Million
50,709 Added 59.27%
136,264 $34.5 Million
Q2 2019

Aug 09, 2019

SELL
$217.4 - $246.08 $19.1 Million - $21.7 Million
-88,041 Reduced 50.72%
85,555 $21.6 Million
Q1 2019

May 10, 2019

BUY
$206.05 - $248.17 $602,284 - $725,400
2,923 Added 1.71%
173,596 $43.4 Million
Q4 2018

Feb 08, 2019

BUY
$204.73 - $257.93 $3.53 Million - $4.44 Million
17,228 Added 11.23%
170,673 $38.5 Million
Q3 2018

Nov 08, 2018

BUY
$233.07 - $256.0 $766,800 - $842,240
3,290 Added 2.19%
153,445 $40 Million
Q2 2018

Aug 10, 2018

BUY
$208.1 - $233.85 $1.18 Million - $1.33 Million
5,679 Added 3.93%
150,155 $36 Million
Q1 2018

May 10, 2018

BUY
$205.46 - $240.27 $784,035 - $916,870
3,816 Added 2.71%
144,476 $31.3 Million
Q4 2017

Feb 09, 2018

SELL
$189.0 - $222.64 $408,240 - $480,902
-2,160 Reduced 1.51%
140,660 $30.1 Million
Q3 2017

Nov 08, 2017

BUY
$186.89 - $198.9 $26.7 Million - $28.4 Million
142,820
142,820 $28 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.